Stock Price
0.13
Daily Change
-0.01 -7.41%
Monthly
13.64%
Yearly
32.98%
Q3 Forecast
0.13

Starpharma Holdings reported AUD20.28M in Cash and Equivalent for its fiscal semester ending in December of 2024.


Cash And Equivalent Change Date
Medical Developments International AUD 17.62M 7.88M Dec/2024
Mesoblast USD 62.56M 14.58M Jun/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024